Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Merck & Co Inc V.MRK


Primary Symbol: MRK

Merck & Co., Inc. is a global health care company. It offers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. The Company’s Pharmaceutical segment includes human health pharmaceuticals and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. It sells these human health pharmaceutical products to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, and health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. The Company’s lead candidate, MK-6070, is a T-cell engager targeting delta-like ligand 3 (DLL3), an inhibitory canonical Notch ligand.


NYSE:MRK - Post by User

Comment by flayeron Aug 21, 2010 12:15am
293 Views
Post# 17371143

RE: Question for the board?

RE: Question for the board?>>>>>So when can we realistically expect to see this new NI 43-101 resource estimate? TIA.<<<<<

I would suggest that if anyone has any questions regarding the upcoming 43 101 resource estimate, exploration plans, future financings etc, to call the company. I had a nice long chat with the President and CEO, Michael Byron, today (Friday Aug 20th). I like what I heard. He knows the geology of the area, has a well defined approach to exploration, has an end-game goal in mind (develop a large ore body and sell it off to the highest bidder), and seems to be very well connected in the sector. Mgnt is key in these types of plays - we have it here. One thing though.....patience is required: we won't be seeing a 43 101 resource estimate next week, but this is a project that can be drilled throughout the winter. Where most plays in the Yukon and NWT are shut down, MKR will be drilling, creating a substantial news flow going forward.
<< Previous
Bullboard Posts
Next >>